MaaT Pharma SA (MAAT.PA)
EUR 5.86
(1.38%)
EUR 5.86
(1.38%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.73 EUR | -23.57% |
| 2022 | -1.40 EUR | 62.86% |
| 2021 | -3.77 EUR | 85.45% |
| 2020 | -25.91 EUR | 19.53% |
| 2019 | -32.20 EUR | -631.82% |
| 2018 | -4.40 EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.53 EUR | -8.16% |
| 2024 Q2 | -0.53 EUR | 0.0% |
| 2023 Q1 | -0.38 EUR | 40.63% |
| 2023 Q2 | -0.76 EUR | -100.0% |
| 2023 FY | - EUR | -23.57% |
| 2023 Q3 | -0.49 EUR | 35.53% |
| 2023 Q4 | -0.49 EUR | 0.0% |
| 2022 FY | - EUR | 62.86% |
| 2022 Q4 | -0.64 EUR | -100.0% |
| 2022 Q3 | -0.32 EUR | 57.33% |
| 2022 Q2 | -0.75 EUR | -97.37% |
| 2022 Q1 | -0.38 EUR | 24.0% |
| 2021 Q4 | -0.50 EUR | 23.08% |
| 2021 FY | - EUR | 85.45% |
| 2021 Q3 | -0.65 EUR | 96.68% |
| 2021 Q2 | -19.60 EUR | -900.0% |
| 2021 Q1 | -1.96 EUR | 87.09% |
| 2020 FY | - EUR | 19.53% |
| 2020 Q3 | -1.52 EUR | 85.52% |
| 2020 Q2 | -10.50 EUR | -900.0% |
| 2020 Q1 | -1.05 EUR | 0.0% |
| 2020 Q4 | -15.18 EUR | -898.68% |
| 2019 FY | - EUR | -631.82% |
| 2018 FY | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -1341.667% |
| ABIVAX Société Anonyme | -3.43 EUR | 49.563% |
| Adocia SA | -1.91 EUR | 9.424% |
| Aelis Farma SA | -0.39 EUR | -343.59% |
| Biophytis S.A. | -12.55 EUR | 86.215% |
| Advicenne S.A. | -0.67 EUR | -158.209% |
| genOway Société anonyme | 0.17 EUR | 1117.647% |
| IntegraGen SA | -0.03 EUR | -6579.537% |
| Medesis Pharma S.A. | -0.80 EUR | -116.25% |
| Neovacs S.A. | -0.00 EUR | -69100.0% |
| NFL Biosciences SA | -0.46 EUR | -276.087% |
| Plant Advanced Technologies SA | 0.07 EUR | 2571.429% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -1801.099% |
| Sensorion SA | -0.17 EUR | -917.647% |
| Theranexus Société Anonyme | -0.88 EUR | -96.591% |
| TME Pharma N.V. | -1.34 EUR | -29.104% |
| Valbiotis SA | -0.59 EUR | -193.22% |
| TheraVet SA | -0.49 EUR | -253.061% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -1053.333% |
| DBV Technologies S.A. | -0.71 EUR | -143.662% |
| Genfit S.A. | -0.58 EUR | -198.276% |
| GeNeuro SA | -0.59 EUR | -193.22% |
| Innate Pharma S.A. | -0.09 EUR | -1738.47% |
| Inventiva S.A. | -2.43 EUR | 28.807% |
| MedinCell S.A. | -0.88 EUR | -96.591% |
| Nanobiotix S.A. | -1.08 EUR | -60.185% |
| OSE Immunotherapeutics SA | -1.18 EUR | -46.61% |
| Poxel S.A. | -0.91 EUR | -90.11% |
| GenSight Biologics S.A. | -0.54 EUR | -220.37% |
| Transgene SA | -0.22 EUR | -686.364% |
| Valneva SE | -0.73 EUR | -136.986% |